Sante Veritas Therapeutics
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $267k | Seed | |
* | $16.0m | Growth Equity VC | |
N/A | Merger | ||
Total Funding | €14.8m |
Related Content
Recent News about Sante Veritas Therapeutics
EditSante Veritas, operating under the umbrella of TILT Holdings, is a diversified Canadian cannabis company with a strong focus on integrating science and nature to produce high-quality medical marijuana products. The company operates in the medical cannabis market and serves a diverse range of clients, including patients, healthcare providers, and other cannabis businesses. Sante Veritas generates revenue through the cultivation and sale of cannabis flower and extracts, as well as through customized client solutions that include branding, packaging, and technology services. The business model is structured around three main units: Retail, Cultivation Production Software Services, and Consumer Devices Packaged Goods. This structure allows the company to leverage its competencies in research, manufacturing, and technology to deliver comprehensive end-to-end services. The company’s facilities in Powell River, British Columbia, are a key asset, and it is a late-stage applicant under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). By focusing on quality, design, and patient accessibility, Sante Veritas aims to make a significant impact in the global cannabis economy.
Keywords: cannabis, medical marijuana, cultivation, production, technology, branding, packaging, healthcare, patient accessibility, ACMPR.